Takeover battles are bad for your health. On Sunday China Vanke, the Hong Kong and Shenzhen-listed property developer in the throes of a tussle for control, delivered first-half results. While profits after tax eked out a rise of one-tenth, this missed market forecasts as margins lost three percentage points (although management said second-half margins should rebound). Growth prospects, however, have been hurt — yet the disruption may ultimately prove good for minority shareholders.
收購戰(zhàn)對健康有害。上周日，萬科(China Vanke)發(fā)布了上半年業(yè)績，這家在香港和深圳上市的房地產開發(fā)商正陷入控制權爭奪戰(zhàn)。雖然2016年上半年萬科的凈利潤勉強實現10%的增長，但遜于市場預期，主營業(yè)務利潤率下降了3個百分點（不過管理層表示下半年利潤率將會回升）。然而，增長前景已受到損害，不過這場動蕩可能最終證明有利于少數股股東。
您已閱讀25%（656字），剩余75%（1927字）包含更多重要信息，訂閱以繼續(xù)探索完整內容，并享受更多專屬服務。